CANSINOBIO (06185): Zuo Min and Ji Xuefeng are elected as independent non-executive directors.
CanSino Biologics (06185) announced that Mr. Zuo Min and Ms. Ji Xuefeng were elected as independent non-executive directors of the third board of directors at the extraordinary general meeting.
CANSINOBIO (06185) announced that Mr. Zuo Min and Ms. Ji Xuefeng were elected as independent non-executive directors of the third board of directors at the extraordinary general meeting.
At the board meeting held immediately after the extraordinary general meeting, the board of directors decided to adjust the composition of the various committees under the board of directors, which will take effect from November 27, 2025 until the end of the third board of directors' term. The details of the adjusted committee composition are as follows:
Audit Committee: Mr. Zhang Yaoliang (Chairman), Ms. Ji Xuefeng, Mr. Li Zhicheng;
Remuneration and Assessment Committee: Mr. Zuo Min (Chairman), Mr. Zhang Yaoliang, Ms. Ji Xuefeng, Mr. Li Zhicheng, Dr. Xuefeng YU;
Nomination Committee: Ms. Ji Xuefeng (Chairman), Mr. Zuo Min, Dr. Xuefeng YU.
Related Articles

ALPHAMAB-B(09966) issued 146,000 shares due to the exercise of options.

MINDTELL TECH (08611) has completed the acquisition of 100% equity of Henan Lixuan Network Technology.

On November 27th, KN Hospital (02120) spent 245,300 Hong Kong dollars to repurchase 22,100 shares.
ALPHAMAB-B(09966) issued 146,000 shares due to the exercise of options.

MINDTELL TECH (08611) has completed the acquisition of 100% equity of Henan Lixuan Network Technology.

On November 27th, KN Hospital (02120) spent 245,300 Hong Kong dollars to repurchase 22,100 shares.

RECOMMEND

Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025

Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025

Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025


